Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7427 p608
18 November 2006

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Letters

· PSNC conference
· NHS fraud
· The profession
· Pfizer products
· 100-hour exemption
· Section 60 Order
· Registration


Letters to the Editor

Pfizer products

Scheme likely to work in opposite way

From Mr R. A. Jephson, MRPharmS

Have I missed something in the fine words that have emanated from Pfizer extolling the virtues of its distribution scheme? Pfizer has stated that the scheme is being put in place to protect the integrity of its prescription medicines. But how will this scheme prevent the legitimate trade of pharmaceutical products entering the UK as parallel imports? How will this scheme prevent the infiltration of this legitimate trade by counterfeit products? Pfizer products are well represented in the lists of those suppliers.

In short, the scheme will not prevent infiltration, but is in fact more likely to be the catalyst to the proliferation of this type of activity which is, of course, the exact opposite to that from which Pfizer hopes to protect patients.

Ray Jephson
Swindon

Send your letter to The Editor

Previous Topic (The profession)
Next Topic (100-hour exemption)

Back to Top


©The Pharmaceutical Journal